Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Evicel, human fibrinogen,human thrombin, Date of authorisation: 05/10/2008, Revision: 18, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 35, Status: Authorised

ICH reflection paper on pursuing opportunities for harmonisation in using real-world data to generate realworld evidence, with a focus on effectiveness of medicines

New pilot programme to support orphan medical devices

European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)

Policy 82: Union Product Database (UPD) Access Policy - Veterinary Medicinal Products

List of medicines currently in PRIME scheme

Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 22-25 July 2024

Human medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised